DXS International PLC (AQU:DXSP)
London · Delayed Price · Currency is GBP · Price in GBX 1.750
0.00 (0.00%)
At close: Oct 21, 2025
DXS International Revenue
DXS International had revenue of 1.73M GBP in the half year ending October 31, 2024, with 4.74% growth. This brings the company's revenue in the last twelve months to 3.35M, down -2.55% year-over-year. In the fiscal year ending April 30, 2024, DXS International had annual revenue of 3.31M, down -2.44%.
Revenue (ttm)
3.35M
Revenue Growth
-2.55%
P/S Ratio
0.33
Revenue / Employee
47.12K
Employees
71
Market Cap
1.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 3.31M | -82.86K | -2.44% |
| Apr 30, 2023 | 3.39M | 106.17K | 3.23% |
| Apr 30, 2022 | 3.29M | -320.72K | -8.89% |
| Apr 30, 2021 | 3.61M | 325.98K | 9.94% |
| Apr 30, 2020 | 3.28M | -66.56K | -1.99% |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |